Patents by Inventor Ariella Kelman

Ariella Kelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING JOINT DAMAGE
    Publication number: 20210024643
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Application
    Filed: May 5, 2020
    Publication date: January 28, 2021
    Applicant: Genentech, Inc.
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • Method for treating joint damage
    Patent number: 10654940
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: May 19, 2020
    Assignees: Genentech, Inc., F. Hoffmann-La Roche AG, Biogen Inc.
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • METHOD FOR TREATING JOINT DAMAGE
    Publication number: 20190382501
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Application
    Filed: July 30, 2019
    Publication date: December 19, 2019
    Applicant: Genentech, Inc.
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • Method for treating joint damage
    Patent number: 10450379
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: October 22, 2019
    Assignees: Genetech, Inc., F. Hoffmann-La Roche AG, Biogen Inc.
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • METHOD FOR TREATING JOINT DAMAGE
    Publication number: 20190270824
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Application
    Filed: April 15, 2019
    Publication date: September 5, 2019
    Applicant: Genentech, Inc.
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • METHOD FOR TREATING JOINT DAMAGE
    Publication number: 20160176974
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Application
    Filed: February 26, 2016
    Publication date: June 23, 2016
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman
  • RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY
    Publication number: 20090269339
    Abstract: The present invention provides clinical data evaluating the efficacy of responses to immunizations in rheumatoid arthritis (RA) patients treated with a CD20 antibody.
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Applicant: Genentech, Inc.
    Inventors: Ariella Kelman, Benjamin L. Trzaskoma
  • Method for treating joint damage
    Publication number: 20090238762
    Abstract: Methods of treating joint damage in a subject eligible for treatment are provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the subject in an amount effective to slow progression of the joint damage as measured by radiography. Further provided are articles of manufacture useful for such methods.
    Type: Application
    Filed: November 14, 2006
    Publication date: September 24, 2009
    Inventors: Mark Totoritis, Timothy Mark Shaw, Sunil Agarwal, David Yocum, Ariella Kelman